Physical Properties of Eu2+-Containing Cryptates as Contrast Agents for Ultrahigh-Field Magnetic Resonance Imaging - Wikidata - wikimedia - TriplyDB

Physical Properties of Eu2+-Containing Cryptates as Contrast Agents for Ultrahigh-Field Magnetic Resonance Imaging

Physical Properties of Eu2+-Containing Cryptates as Contrast Agents for Ultrahigh-Field Magnetic Resonance Imaging

http://www.wikidata.org/entity/Q24617694

about

Lanthanide probes for bioresponsive imaging Overcoming the concentration-dependence of responsive probes for magnetic resonance imaging Oxidation-Responsive, EuII/III-Based, Multimodal Contrast Agent for Magnetic Resonance and Photoacoustic Imaging Redox- and hypoxia-responsive MRI contrast agents.A Eu(II)-Containing Cryptate as a Redox Sensor in Magnetic Resonance Imaging of Living Tissue.Enhancing magnetic resonance imaging with contrast agents for ultra-high field strengths Oxidation-responsive Eu(2+/3+)-liposomal contrast agent for dual-mode magnetic resonance imaging.Aqueous Eu(II)-Containing Complex with Bright Yellow Luminescence Research into europium complexes as magnetic resonance imaging contrast agents (Review)Developments in the Coordination Chemistry of Europium(II).Interaction of Biphenyl-Functionalized Eu(2+)-Containing Cryptate with Albumin: Implications to Contrast Agents in Magnetic Resonance Imaging Aqueous Lanthanide Chemistry in Asymmetric Catalysis and Magnetic Resonance Imaging.Evaluation of Eu(II) -based positive contrast enhancement after intravenous, intraperitoneal, and subcutaneous injections.Structural Features of Europium(II)-Containing Cryptates That Influence Relaxivity.Spectroscopic Characterization of the 3+ and 2+ Oxidation States of Europium in a Macrocyclic Tetraglycinate Complex.Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus.Synthesis, Characterization, and Handling of EuII-Containing Complexes for Molecular Imaging Applications.Fluorinated EuII-based multimodal contrast agent for temperature- and redox-responsive magnetic resonance imaging.

P2860

Q27000361-5E3DA11F-4F31-47C3-9902-EE29D0FDCB84 Q27013727-7D1AD4A1-3A4A-4BE6-B237-385E484CB68A Q30359425-D2A72A99-B4F2-4D39-8AC1-C48A74686DCC Q30820031-D21E6EF1-95EC-4590-9A88-D89E0C9C1461 Q31000314-28F777AB-652A-4273-AAD7-89021BCD7F04 Q34071930-023770DB-641F-4601-A109-79833B7D62BC Q34429253-8BDE5A61-8CFA-481A-B5DB-FFBF9384DFEF Q35528676-48F87315-42CE-4EDB-8C0E-B79C1D4CABA2 Q35753935-2C15DBB8-6B5A-4CE3-8A68-FEDEDC21E167 Q36292078-BED27554-D3F1-4EEA-82BD-B61193B58514 Q36393668-317584D8-61B6-4E38-84C6-35A63C0A137E Q37143146-C1747F1D-342B-4D13-B9AF-992515B697CA Q37143467-6C462C48-FB62-48C3-80EA-FE1F9F126395 Q38657746-2130E936-F1BC-4D00-B34C-E0E64C81772F Q39722949-64BCBB24-3B76-48F5-955D-3BCB84872BED Q46158473-63CFA4BD-78A1-4877-B679-C4DD7C9E0497 Q55069856-273AC15B-B089-41ED-BEA7-6FC14F72AF14 Q55086950-8FB236D2-3009-4E86-B4C9-C5F0040E3E62

P2860

Physical Properties of Eu2+-Containing Cryptates as Contrast Agents for Ultrahigh-Field Magnetic Resonance Imaging

http://www.wikidata.org/entity/Q24617694

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Physical Properties of Eu2+-Co ...... eld Magnetic Resonance Imaging

@ast

Physical Properties of Eu2+-Co ...... eld Magnetic Resonance Imaging

@en

Physical Properties of Eu2+-Co ...... eld Magnetic Resonance Imaging

@nl

type

label

Physical Properties of Eu2+-Co ...... eld Magnetic Resonance Imaging

@ast

Physical Properties of Eu2+-Co ...... eld Magnetic Resonance Imaging

@en

Physical Properties of Eu2+-Co ...... eld Magnetic Resonance Imaging

@nl

prefLabel

Physical Properties of Eu2+-Co ...... eld Magnetic Resonance Imaging

@ast

Physical Properties of Eu2+-Co ...... eld Magnetic Resonance Imaging

@en

Physical Properties of Eu2+-Co ...... eld Magnetic Resonance Imaging

@nl

P1433

Q24617694-AB7CB0D2-D9A8-4AF1-99BE-A319E0C0B012

P1476

Q24617694-58AE17D0-6AF5-4A15-93CC-0CF877FBE24D

P2093

Q24617694-240B352B-8087-485A-8B27-6B016DD5D8A0

Q24617694-798B5E69-3C43-46DF-B2D9-86E16AEE157E

Q24617694-F5792698-B1DB-407D-A111-45E16CB7CB52

P2860

Q24617694-0E83234B-2AB7-4B47-B6DB-AC43E1716B89

Q24617694-127F67C8-4BE5-4714-93A8-EAEAE997AEA6

Q24617694-3880C2E4-87BB-447D-BFAC-5A67A2E62DD1

Q24617694-62D5EB99-FDE9-4660-B225-A25B4F92CA5E

Q24617694-7EB56449-B909-4CAC-A2AB-B35E819DA770

Q24617694-7EB62815-1F20-4994-948B-494EDB1A97F0

Q24617694-888934B1-FF58-4B36-B6CC-EEFEBD5AC514

Q24617694-9084E617-DC4B-4E8A-BFA3-463FD5AA6F60

Q24617694-A7D87EE1-8B93-45A4-A856-ECE08479C622

Q24617694-B2455271-B593-47AB-9B77-F66FCC73D269

P304

Q24617694-0A4842ED-53F2-4413-917D-F5A0E7F84C6A

P31

Q24617694-F73C5777-C6BD-4F0E-805C-B1F793A82D20

P356

Q24617694-194FB5DF-DB08-4BEF-8DBF-FE5C80C78FF0

P433

Q24617694-9269946A-3C4A-450D-87A4-3DA25985D4AE

P478

Q24617694-4DA92F1D-F18E-49FF-9248-E24C305F8ACA

P577

Q24617694-FF1F5AED-6C72-4EC2-A9AE-723F9D7385B6

P5875

Q24617694-C498E201-4C82-490B-907B-7BDDECCA9E97

P698

Q24617694-1B546CEB-A173-4DE8-88DA-EEEA0BC9E59B

P932

Q24617694-2226ADD6-6E00-415E-ADE7-F841E9611460

P356

P1433

European Journal of Inorganic Chemistry

P1476

Physical Properties of Eu2+-Co ...... eld Magnetic Resonance Imaging

@en

P2093

Akhila N W Kuda-Wedagedara

http://www.w3.org/2001/XMLSchema#string

Joel Garcia

http://www.w3.org/2001/XMLSchema#string

Matthew J Allen

http://www.w3.org/2001/XMLSchema#string

P2860

What nephrologists need to know about gadolinium

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications

Rapid chromatographic technique for preparative separations with moderate resolution

EuII-cryptate with optimal water exchange and electronic relaxation: a synthon for potential pO2 responsive macromolecular MRI contrast agents.

Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents.

Extensive NMRD studies of Ni(II) salt solutions in water and water-glycerol mixtures.

Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents

How to measure the transmetallation of a gadolinium complex.

Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications.

P304

2135-2140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJIC.201101166

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225066263

http://www.w3.org/2001/XMLSchema#string

P698

22639543

http://www.w3.org/2001/XMLSchema#string

P932

3358779

http://www.w3.org/2001/XMLSchema#string